CRISPR And CRISPR-Associated (Cas) Genes Market To Reach USD 4.09 Billion By 2025: Hexa ReportsMedgadget (blog)The Clustered regularly interspaced short palindromic repeats CRISPR and CRISPR-associated (Cas) Genes Market is anticipated to reach USD … Continue reading
|
Immunotherapy for Recurrent HNSCC
OncLive Therefore, the field of immunotherapy in cancer held promise that we could potentially, for a recurrent metastatic cancer patient, induce their immune system response against their cancer, providing long-term durability—the so-called tail of the curve … |
OncLive |
Dr. Smith on Immunotherapy Potential in Multiple Myeloma
OncLive Although the disease is still considered incurable, immunotherapy is a hopeful way to shift that paradigm and get durable responses—or even cures—in patients. Additionally, he says, monoclonal antibodies such as upfront daratumumab (Darzalex) could … |
|
Developments in Immunotherapy at PCOC
AJMC.com Managed Markets Network Another exciting field in immunotherapy is of chimeric antigen receptor (CAR)-T cells. To provide an overview of this evolving field, The American Journal of Managed Care® invited David L. Porter, MD, director, Bone Marrow Transplantation; Jodi Fisher … |
|
Saitama clinic ordered to halt unauthorized stem cell ‘anti-aging’ therapy using umbilical cord blood
The Japan Times Saitama Medical Clinic in Tokorozawa, Saitama Prefecture, was found to have been engaged in such therapy without getting permission from the ministry. The regenerative medicine safety law mandates that all hospitals and clinics submit plans for stem … |